ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA.

May 26, 2000

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

Antidepressant Provides Cool Choice For Hot Flashes

February 22, 2002